Browse Topic
Urology
-
August 10, 2023Cancer researcher gets federal funding to test immunotherapy in drug-resistant prostate cancer
UC Davis Comprehensive Cancer Center scientist receives $1.4 million federal grant to boost efforts finding a breakthrough treatment for late stage, drug-resistant prostate cancer.
Read More
-
May 08, 2023Strong link between bone biomarkers and prostate cancer survival
Bone disease in prostate cancer patients can be devastating, but new research led by UC Davis Comprehensive Cancer Center aims to improve the odds.
Read More
-
March 21, 2023UC Davis urologic surgery chair earns prestigious award in Europe
UC Davis Health urologic surgery chief Christopher Evans is only the ninth American to become an honorary member of the European Association of Urology.
Read More
-
February 15, 2023UC Davis School of Medicine receives record amount of NIH funding for second year in a row
In 2022, the UC Davis School of Medicine scored a record amount of NIH research funding — more than $200 million in grants. This placed UC Davis among the nation’s best medical schools, ranking 32nd nationally.
Read More -
February 10, 2023New compound shows promise against treatment-resistant prostate cancers
UC Davis Health urologist Allen Gao and his team have developed a molecule, called LX-1, which could help control treatment-resistant prostate cancer.
Read More
-
July 18, 2022New procedure transforms grafts used in bladder augmentation surgeries
UC Davis Pediatric Urologist Eric Kurzrock devised a new procedure to create graft tissues with functioning blood vessels needed in bladder augmentation surgeries. His innovative method solves the tissue contraction issue, a common problem in bioengineered graft implants.
Read More
-
April 28, 2021Male bladder cancer vulnerability could lead to a new treatment approach
UC Davis Comprehensive Cancer Center researchers found that targeting androgen receptors - a type of protein specific to men - may destroy cancer cells. Focusing on this male protein variant common in malignant bladder tumor cells may serve as a new avenue for treating bladder cancer in men.
Read More
